Evotec SE (EVO) Net Income towards Common Stockholders (QoQ) (2009 - 2025)
Powered by 
Analysis
Evotec SE (EVO) Net Income towards Common Stockholders (QoQ) (2009 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 33.56% |
| Sep 30, 2025 | -59.27% |
| Jun 30, 2025 | -6.27% |
| Mar 31, 2025 | 65.17% |
| Dec 31, 2024 | -42.91% |
| Sep 30, 2024 | 47.24% |
| Jun 30, 2024 | -215.26% |
| Mar 31, 2024 | -4.04% |
| Dec 31, 2022 | -41.78% |
| Sep 30, 2022 | 259.90% |
| Jun 30, 2022 | 63.74% |
| Mar 31, 2022 | -128.28% |
| Dec 31, 2021 | -122.74% |
| Sep 30, 2021 | 119.09% |
| Jun 30, 2021 | 13.69% |
| Mar 31, 2021 | 12,328.54% |
| Dec 31, 2020 | 131.06% |
| Sep 30, 2010 | -8.28% |
| Jun 30, 2010 | 85,066.83% |
| Mar 31, 2010 | 99.99% |